The 9 most recent market catalysts affecting $CELU, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 24, 2026
Corporate Catalyst
Bullish
Impact 75
Celularity shares are trading higher after the company announced an initial closing generating over $10 million in gross cash proceeds from a private placement of senior secured convertible notes and warrants.
This headline signals a significant positive development for Celularity, as securing over $10 million in gross cash proceeds alleviates immediate financial pressures and provides c…
Sep 24, 2026
Corporate Catalyst
Bullish
Impact 75
Celularity Announces Initial Closing Generating Over $10M In Gross Cash Proceeds From Private Placement Of Senior Secured Convertible Notes And Warrants
Celularity has secured over $10 million in new capital through convertible notes and warrants, which is a crucial step in its recapitalization plan. This funding, combined with the…
Sep 14, 2026
Corporate Catalyst
Neutral
Impact 55
Celularity Says It Regained Compliance With Nasdaq Minimum Bid Price And Market Value Of Listed Securities Rules; Delinquent Periodic Filing Deficiency Remains Outstanding
Celularity (CELU) filed an 8-K to inform investors that it has satisfied two of the three Nasdaq compliance deficiencies it previously faced: the minimum bid price and the market v…
Aug 27, 2026
Market Technicals
Bullish
Impact 55
12 Health Care Stocks Moving In Thursday's Intraday Session
This 8-K filing, generated by an automated content engine, reports on the intraday performance of 12 health care stocks. The significant volatility, particularly the triple-digit g…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 75
Reported Earlier: Celularity And MuseCell Innovations Expand U.S. Manufacturing Collaboration, With Potential For $300M+ In Purchases Over Five Years
Celularity Inc. (CELU) has expanded its manufacturing collaboration with MuseCell Innovations, taking on the U.S. production of Dezawa MuseCells and derived products. This is a sig…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 75
Celularity shares are trading higher after the company announced an additional U.S.-based manufacturing collaboration under which Celularity will undertake activities to establish U.S. production of Dezawa MuseCells at Celularity’s Florham Park, New Jersey facility.
This announcement is a significant positive catalyst for Celularity, as it addresses critical aspects of product commercialization: manufacturing capacity and supply chain resilien…
Aug 27, 2026
Corporate Catalyst
Neutral
Impact 75
Celularity To Begin U.S. Production Of MuseCell Innovations' Dezawa MuseCells At Its New Jersey Facility
Celularity (CELU) has announced a significant collaboration with MuseCell Innovations (MCI) to become the U.S. manufacturer for MCI's Dezawa MuseCells and derived products. This pa…
Aug 26, 2026
Corporate Catalyst
Bearish
Impact 85
Reported Earlier, Celularity Receives Nasdaq Non-Compliance Notice Over Delinquent Q1 And Q2 2026 Form 10-Q Filings
This headline indicates a severe corporate governance and financial reporting issue for Celularity. Delinquent filings often precede further negative news, such as restatements, au…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.